Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
BEIJING, July 8 (Reuters) - A cybersecurity platform operated by China's industry ministry warned on Wednesday that it had ...
As the Burnout and Need For Speed developer turns 30, let’s remember it’s about more than Battlefield.